State Street’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
Other funds holding ARLZ
PCM
BC
JAM
AC
DM
JHIU
ECP
TLCM
PI
State Street's ARLZ Position: Q2 2016 in Review
State Street sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2016, closing a stake of 790,730 shares — an estimated $2.81M sold.
State Street first reported a position in ARLZ in Q1 2016 and held it in 1 quarter. The position peaked at $2.81M in Q1 2016. 95 funds tracked by Wall St. Rank hold ARLZ as of Q2 2016.
- State Street reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
- State Street sold 790,730 Aralez Pharmaceuticals Inc. shares in Q2 2016, an estimated $2.81M.
- State Street first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 1 quarter.
- State Street's Aralez Pharmaceuticals Inc. position peaked at $2.81M in Q1 2016.
- 95 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2016.
Based on State Street's 13F filing for Q2 2016, filed 12 Aug 2016.